(Q48684038)

14 February 2018

title

Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's disease. (English)

1 reference

14 February 2018

0 references

13

Möller HJ

1 reference

14 February 2018

author name string

Hampel H

1

1 reference

14 February 2018

Schoen D

2

1 reference

14 February 2018

Schwarz MJ

3

1 reference

14 February 2018

Kötter HU

4

1 reference

14 February 2018

Schneider C

5

1 reference

14 February 2018

Sunderland T

6

1 reference

14 February 2018

Dukoff R

7

1 reference

14 February 2018

Levy J

8

1 reference

14 February 2018

Padberg F

9

1 reference

14 February 2018

Stübner S

10

1 reference

14 February 2018

Buch K

11

1 reference

14 February 2018

Müller N

12

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 June 1997

1 reference

14 February 2018

published in

Neuroscience Letters

1 reference

14 February 2018

volume

228

1 reference

14 February 2018

page(s)

143-146

1 reference

14 February 2018

issue

3

1 reference

14 February 2018

Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900379-0

7 January 2021

Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900379-0

7 January 2021

Regulation of the release of interleukin-6 from human astrocytoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900379-0

7 January 2021

Elevated circulating tumor necrosis factor levels in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900379-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900379-0

1 reference

7 January 2021

17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900379-0

7 January 2021

Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900379-0

7 January 2021

Interleukin-6-associated inflammatory processes in Alzheimer's disease: new therapeutic options.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900379-0

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900379-0

7 January 2021

Soluble interleukin-6 receptor is released from receptor-bearing cell lines in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900379-0

7 January 2021

Serum levels of interleukin-6 and acute phase responses

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900379-0

7 January 2021

Soluble cytokine receptors are present in normal human urine

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900379-0

7 January 2021

Receptors for B-cell stimulatory factor-1 expressed on cells of haematopoietic lineage

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900379-0

7 January 2021

Induction of neuronal differentiation in PC12 cells by B-cell stimulatory factor 2/interleukin 6

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900379-0

7 January 2021

Patterns of risk in first-degree relatives of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900379-0

7 January 2021

Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900379-0

7 January 2021

Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900379-0

7 January 2021

Decreased interleukin-6 level in the cerebrospinal fluid of patients with Alzheimer-type dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900379-0

7 January 2021

Purification and characterization of soluble human IL-6 receptor expressed in CHO cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900379-0

7 January 2021

10.1016/S0304-3940(97)00379-0

Identifiers

DOI

1 reference

14 February 2018

PubMed ID

9218628

1 reference

14 February 2018